The PE Ratio as of November 2024 (TTM) for ABVC BioPharma, Inc. (ABVC) is -0.68

According to ABVC BioPharma, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.68. This represents a change of -82.15% compared to the average of -3.81 of the last 4 quarters.

ABVC BioPharma, Inc. (ABVC) Historical PE Ratio (quarterly & annually)

How has ABVC PE Ratio performed in the past?

The mean historical PE Ratio of ABVC BioPharma, Inc. over the last ten years is -1344.77. The current -0.68 PE Ratio has changed -94.94% with respect to the historical average. Over the past ten years (40 quarters), ABVC's PE Ratio was at its highest in in the December 2015 quarter at 33.19K. The PE Ratio was at its lowest in in the September 2015 quarter at -12153.92.

ABVC BioPharma, Inc. (ABVC) PE Ratio by Quarter and Year

Discovering the peaks and valleys of ABVC BioPharma, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ABVC BioPharma, Inc. (ABVC) Average PE Ratio

How has ABVC PE Ratio performed in the past?

The current PE Ratio of ABVC BioPharma, Inc. (ABVC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

ABVC BioPharma, Inc. (ABVC) PE Ratio vs. Peers

How is ABVC’s PE Ratio compared to its peers?

ABVC BioPharma, Inc.’s PE Ratio is less than Indaptus Therapeutics, Inc. (-0.64), less than Pasithea Therapeutics Corp. (-0.00), less than Better Therapeutics, Inc. (-0.00), greater than Forte Biosciences, Inc. (-0.86), less than Evelo Biosciences, Inc. (-0.00), less than Aptinyx Inc. (-0.06), less than Magenta Therapeutics, Inc. (-0.15), greater than Aileron Therapeutics, Inc. (-1.83), less than Aridis Pharmaceuticals, Inc. (0.00), greater than Akari Therapeutics, Plc (-0.81), less than Aditxt, Inc. (-0.00), greater than Acasti Pharma Inc. (-3.10), greater than RenovoRx, Inc. (-3.51), greater than Anebulo Pharmaceuticals, Inc. (-4.78), less than SAB Biotherapeutics, Inc. (-0.64), less than Monopar Therapeutics Inc. (-0.54), less than Eledon Pharmaceuticals, Inc. (17.15), greater than Nutriband Inc. (-7.34), less than Quoin Pharmaceuticals, Ltd. (-0.33), greater than Longeveron Inc. (-1.44), less than Virax Biolabs Group Limited (-0.67),

Build a custom stock screener for ABVC BioPharma, Inc. (ABVC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ABVC BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ABVC BioPharma, Inc. (ABVC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ABVC BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.